Clinical Presentation and Management of Coronavirus Disease 2019 in Renal Allograft Recipients: A Case Series

    Published on:September 2021
    Journal of Young Pharmacists, 2021; 13(3):309-311
    Case Report | doi:10.5530/jyp.2021.13.62

    Abhijith C1, Archin Ann Jacob1, Sukanya Yesodhar1, Sulfath TS2,*

    1Department of Pharmacy Practice, S.C.S College of Pharmacy, Harapanahalli, Karnataka, INDIA.

    2Clinical Pharmacist, IQRAA International Hospital and Research Centre, Calicut, Kerala, INDIA.


    Complications of coronavirus disease 2019 infection in renal transplant recipients are associated with significant morbidity and mortality and the existence of co-morbidities are more likely to develop serious illness. In this case series the clinical outcomes of coronavirus disease 2019 in 6 recipients tested positive is explained. D-dimer, ferritin and C-reactive protein values are elevated in all cases. The patients were on immunosuppressant therapy and had stable graft function before coronavirus disease 2019 infection. After the diagnosis, management included reduction and withdrawal of immunosuppression and significant changes in corticosteroids. One of our patients showed significant improvement without dosage adjustment of immunosuppressant.

    Key words: Severe acute respiratory syndrome coronavirus 2, Rapid antigen test, Mycophenolate mofetil, Tacrolimus, Intravenous immunoglobulin.

    Article Download